LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 63 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $532,000 | -52.7% | 230,121 | -6.3% | 0.02% | -44.1% |
Q3 2021 | $1,124,000 | +1.5% | 245,492 | -1.5% | 0.03% | 0.0% |
Q2 2021 | $1,107,000 | -39.9% | 249,256 | -1.5% | 0.03% | -35.8% |
Q1 2021 | $1,843,000 | -3.4% | 253,102 | +1.2% | 0.05% | -23.2% |
Q4 2020 | $1,908,000 | – | 250,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 8,466,783 | $5,758,000 | 0.09% |
HARBOR CAPITAL ADVISORS, INC. | 226,731 | $154,000 | 0.07% |
Sio Capital Management, LLC | 182,630 | $124,000 | 0.04% |
Virtu Financial LLC | 71,475 | $49,000 | 0.00% |
Independence Bank of Kentucky | 10,200 | $7,000 | 0.00% |
SANDERS MORRIS HARRIS LLC | 15,000 | $10,000 | 0.00% |
Endurance Wealth Management, Inc. | 1,500 | $12,000 | 0.00% |
Baker Brothers Advisors | 451,478 | $307,000 | 0.00% |
Texas Yale Capital Corp. | 20,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 79,900 | $54,000 | 0.00% |